Literature DB >> 33546061

Involuntary movement in stiff-person syndrome with amphiphysin antibodies: A case report.

Yin-Yin Xie1, Hong-Mei Meng1, Feng-Xiao Zhang1, Buajieerguli Maimaiti1, Ting Jiang1, Yu Yang2.   

Abstract

RATIONALE: Stiff-person syndrome (SPS) is a rare neurological immune disorder characterized by progressive axial and proximal limb muscle rigidity, stiffness, and painful muscle spasms. Amphiphysin antibodies are positive in approximately 5% of SPS patients. To date, there have been no relevant reports on involuntary movement in cases of SPS with amphiphysin antibodies. PATIENT CONCERNS: We describe the case of a 69-year-old man with a 2-year history of progressive stiffness in the neck, bilateral shoulders, and chest muscles, and a more-than-a-year history of dyspnea accompanied by mandibular involuntary movement. The patient was a vegetarian and had good health in the past. The family's medical history was unremarkable. DIAGNOSES: He was diagnosed with SPS based on the progressive muscle stiffness, the amphiphysin antibody seropositivity, the continuous motor activity on electromyography, and the effective treatment with benzodiazepines.
INTERVENTIONS: The patient was orally administered clonazepam and baclofen, and corticosteroid IV followed by prednisone orally. OUTCOMES: In the hospital, after treatment with methylprednisolone, clonazepam, and baclofen, the patient's rigidity, stiffness, and dyspnea significantly improved. The involuntary movement of the mandible persisted throughout the treatment process. Currently, under oral treatment with baclofen and clonazepam, the patient's symptoms of muscle stiffness and dyspnea exist, and follow-up is continued. LESSONS: We report a rare and novel case of involuntary movement in SPS with amphiphysin antibodies. The present report explores the relationship between SPS and involuntary movement and expands the spectrum of clinical manifestations of SPS.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33546061      PMCID: PMC7837982          DOI: 10.1097/MD.0000000000024312

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  36 in total

1.  The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome.

Authors:  M C Dalakas; M Fujii; M Li; B McElroy
Journal:  Neurology       Date:  2000-11-28       Impact factor: 9.910

Review 2.  Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus.

Authors:  M Solimena; P De Camilli
Journal:  Trends Neurosci       Date:  1991-10       Impact factor: 13.837

3.  Case report of a woman with anti amphiphysin positive stiff person syndrome.

Authors:  Nóra Manhalter; Orsolya Györfi; Erzsébet Boros; Magdolna Bokor; Ferenc Fazekas; Zoltán Dénes; Dániel Fabó; Anita Kamondi; Loránd Erőss
Journal:  Ideggyogy Sz       Date:  2017-05-30       Impact factor: 0.427

4.  Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.

Authors:  Anna Boronat; Jeffrey M Gelfand; Nuria Gresa-Arribas; Hyo-Young Jeong; Michael Walsh; Kirk Roberts; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Bernardo Rudy; Josep Dalmau
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

5.  Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies.

Authors:  Bettina Balint; Sven Jarius; Simon Nagel; Uwe Haberkorn; Christian Probst; Inga Madeleine Blöcker; Ramona Bahtz; Lars Komorowski; Winfried Stöcker; Andreas Kastrup; Martin Kuthe; Hans-Michael Meinck
Journal:  Neurology       Date:  2014-04-02       Impact factor: 9.910

6.  Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome.

Authors:  Divyanshu Dubey; Jiraporn Jitprapaikulsan; Hongyan Bi; Rocio Vazquez Do Campo; Andrew McKeon; Sean J Pittock; Janean K Engelstad; John R Mills; Christopher J Klein
Journal:  Neurology       Date:  2019-10-17       Impact factor: 9.910

7.  Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.

Authors:  Alexander Carvajal-González; M Isabel Leite; Patrick Waters; Mark Woodhall; Ester Coutinho; Bettina Balint; Bethan Lang; Philippa Pettingill; Aisling Carr; Una-Marie Sheerin; Rayomand Press; Raomand Press; Michael P Lunn; Ming Lim; Paul Maddison; H-M Meinck; Wim Vandenberghe; Angela Vincent
Journal:  Brain       Date:  2014-06-20       Impact factor: 13.501

8.  Glycine receptor autoantibodies disrupt inhibitory neurotransmission.

Authors:  Sarah J Crisp; Christine L Dixon; Leslie Jacobson; Elodie Chabrol; Sarosh R Irani; M Isabel Leite; Guy Leschziner; Sean J Slaght; Angela Vincent; Dimitri M Kullmann
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

Review 9.  Pragmatic Treatment of Stiff Person Spectrum Disorders.

Authors:  Bettina Balint; Hans-Michael Meinck
Journal:  Mov Disord Clin Pract       Date:  2018-07-19

10.  Glycine receptors in the striatum, globus pallidus, and substantia nigra of the human brain: an immunohistochemical study.

Authors:  Henry J Waldvogel; Kristin Baer; Kathryn L Allen; Mark I Rees; Richard L M Faull
Journal:  J Comp Neurol       Date:  2007-06-20       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.